Coloplast Income Statement

Financials in millions DKK. Fiscal year is October - September.

Millions DKK. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Revenue	27,874	27,030	24,500	22,579	19,426
Revenue Growth (YoY)	3.12%	10.33%	8.51%	16.23%	4.76%
Cost of Revenue	8,929	8,761	8,172	7,050	6,113
Gross Profit	18,945	18,269	16,328	15,529	13,313
Selling, General & Admin	10,420	10,069	8,633	7,802	6,247
Research & Development	946	913	872	866	755
Other Operating Expenses	-140	-22	-25	-56	-48
Operating Expenses	11,224	10,960	9,479	8,610	6,956
Operating Income	7,721	7,309	6,849	6,919	6,357
Interest Expense	-753	-795	-638	-172	-25
Interest & Investment Income	102	155	111	39	11
Currency Exchange Gain (Loss)	-231	-218	-178	-134	114
Other Non Operating Income (Expenses)	-118	-85	-78	-66	-31
EBT Excluding Unusual Items	6,721	6,366	6,066	6,586	6,426
Merger & Restructuring Charges	-78	-89	-118	-171	-
Gain (Loss) on Sale of Assets	-49	-23	-3	-7	-4
Legal Settlements	-	-	-200	-300	-200
Other Unusual Items	-437	141	280	19	11
Pretax Income	6,157	6,395	6,025	6,127	6,233
Income Tax Expense	2,521	1,343	1,242	1,421	1,408
Net Income	3,636	5,052	4,783	4,706	4,825
Net Income to Common	3,636	5,052	4,783	4,706	4,825
Net Income Growth	-28.03%	5.62%	1.64%	-2.47%	14.96%
Shares Outstanding (Basic)	225	225	215	213	213
Shares Outstanding (Diluted)	225	225	216	213	213
Shares Change (YoY)	0.22%	4.36%	1.27%	-0.19%	-0.05%
EPS (Basic)	16.13	22.46	22.21	22.15	22.67
EPS (Diluted)	16.13	22.46	22.20	22.11	22.63
EPS Growth	-28.18%	1.17%	0.41%	-2.30%	15.05%
Free Cash Flow	5,339	1,600	3,206	4,172	4,371
Free Cash Flow Per Share	23.69	7.11	14.88	19.61	20.50
Dividend Per Share	23.000	22.000	21.000	20.000	19.000
Dividend Growth	4.54%	4.76%	5.00%	5.26%	5.56%
Gross Margin	67.97%	67.59%	66.64%	68.78%	68.53%
Operating Margin	27.70%	27.04%	27.96%	30.64%	32.72%
Profit Margin	13.04%	18.69%	19.52%	20.84%	24.84%
Free Cash Flow Margin	19.15%	5.92%	13.09%	18.48%	22.50%
EBITDA	8,630	8,191	7,568	7,544	6,897
EBITDA Margin	30.96%	30.30%	30.89%	33.41%	35.50%
D&A For EBITDA	909	882	719	625	540
EBIT	7,721	7,309	6,849	6,919	6,357
EBIT Margin	27.70%	27.04%	27.96%	30.64%	32.72%
Effective Tax Rate	40.95%	21.00%	20.61%	23.19%	22.59%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.